Form Type: 4

SEC EDGAR Link
Accession Number:0001415889-21-003664
Date:2021-07-20
Issuer: OLEMA PHARMACEUTICALS, INC. (OLMA)
Original Submission Date:

Reporting Person:

HARMON CYRUS
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR SAN FRANCISCO, CA 94107

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-07-19 S 7,877 d $24.83 1,091,669 direct
COMMON STOCK 2021-07-20 S 4,123 d $25.63 1,087,546 direct
COMMON STOCK 2021-07-20 0 $0.00 122,028 indirect f4
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
f2 the weighted average sale price for the transaction reported was $24.83, and the range of prices were between $24.75 and $24.95. upon request from the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f3 the weighted average sale price for the transaction reported was $25.63, and the range of prices were between $25.14 and $26.10. upon request from the sec staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
f4 the shares are held by the harmon family investors llc, of which the reporting person is the manager.

Elevate your investments